Piclamilast
≥99%
- Product Code: 109477
CAS:
144035-83-6
| Molecular Weight: | 381.25 g./mol | Molecular Formula: | C₁₈H₁₈Cl₂N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Piclamilast is primarily used in the field of medical research and pharmacology due to its role as a selective phosphodiesterase-4 (PDE4) inhibitor. It is studied for its potential anti-inflammatory properties, making it a candidate for treating inflammatory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and psoriasis. By inhibiting PDE4, it helps reduce the production of pro-inflammatory mediators and promotes the release of anti-inflammatory substances, which can alleviate symptoms associated with these conditions. Additionally, Piclamilast has been explored for its potential in treating neurodegenerative diseases like Alzheimer’s, as inflammation plays a key role in their progression. Its application in clinical trials continues to assess its efficacy and safety for therapeutic use.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $500.84 |
+
-
|
| 0.010 | 10-20 days | $800.97 |
+
-
|
| 0.025 | 10-20 days | $1,735.75 |
+
-
|
Piclamilast
Piclamilast is primarily used in the field of medical research and pharmacology due to its role as a selective phosphodiesterase-4 (PDE4) inhibitor. It is studied for its potential anti-inflammatory properties, making it a candidate for treating inflammatory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and psoriasis. By inhibiting PDE4, it helps reduce the production of pro-inflammatory mediators and promotes the release of anti-inflammatory substances, which can alleviate symptoms associated with these conditions. Additionally, Piclamilast has been explored for its potential in treating neurodegenerative diseases like Alzheimer’s, as inflammation plays a key role in their progression. Its application in clinical trials continues to assess its efficacy and safety for therapeutic use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :